Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
Marina Peball, Florian Krismer, Hans‐Günther Knaus, et al.
Annals of Neurology (2020) Vol. 88, Iss. 4, pp. 712-722
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Inflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 775
The neuropsychiatry of Parkinson's disease: advances and challenges
Daniel Weintraub, Dag Aarsland, К. Ray Chaudhuri, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 89-102
Open Access | Times Cited: 155
Cannabinoids: Therapeutic Use in Clinical Practice
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3344-3344
Open Access | Times Cited: 145
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
Ainhoa Bilbao, Rainer Spanagel
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 107
Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature
Ana Isabel Beltrán-Velasco, Manuel Reiriz, Sara Uceda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3010-3010
Open Access | Times Cited: 17
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
Barbara Stella, Francesca Baratta, Carlo Della Pepa, et al.
Drugs (2021) Vol. 81, Iss. 13, pp. 1513-1557
Open Access | Times Cited: 99
MicroRNA Dysregulation in Parkinson’s Disease: A Narrative Review
Yong Hui Nies, Nor Haliza Mohamad Najib, Wei Ling Lim, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 76
Management of psychiatric and cognitive complications in Parkinson’s disease
Daniel Weintraub, Dag Aarsland, Roberta Biundo, et al.
BMJ (2022), pp. e068718-e068718
Open Access | Times Cited: 47
Pharmacological Treatment of Tremor in Parkinson’s Disease Revisited
Walter Pirker, Regina Katzenschlager, Mark Hallett, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 2, pp. 127-144
Open Access | Times Cited: 39
Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature
Dianna Wolfe, Kim Corace, Claire Butler, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281826-e0281826
Open Access | Times Cited: 30
Short‐Term Cannabidiol with Δ‐9‐Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial
Ying Liu, Jacquelyn Bainbridge, Stefan Sillau, et al.
Movement Disorders (2024) Vol. 39, Iss. 5, pp. 863-875
Open Access | Times Cited: 9
Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials
Mahmood AminiLari, Li Wang, Samuel Neumark, et al.
SLEEP (2021) Vol. 45, Iss. 2
Open Access | Times Cited: 53
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Ana Bernal‐Chico, Vanja Tepavčević, Andrea Manterola, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 103-126
Open Access | Times Cited: 29
Metabolomic profiling reveals altered phenylalanine metabolism in Parkinson’s disease in an Egyptian cohort
Nourhan Shebl, Shaimaa I El-Jaafary, Ayman A. Saeed, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 7
Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis
Latha Velayudhan, Katie McGoohan, Sagnik Bhattacharyya
PLoS Medicine (2021) Vol. 18, Iss. 3, pp. e1003524-e1003524
Open Access | Times Cited: 38
Effects of Cannabis in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Berzenn Urbi, Joel Corbett, Ian Hughes, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 2, pp. 495-508
Open Access | Times Cited: 38
Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology
Alessandra Fanciulli, Friederike Sixel‐Döring, Carsten Buhmann, et al.
Journal of Neurology (2025) Vol. 272, Iss. 1
Open Access
Neuropsychiatric Manifestations in Parkinson Disease
Daniel Weintraub, Julia Gallagher, Matthew Stern
Cambridge University Press eBooks (2025), pp. 155-165
Closed Access
Pipeline of Pharmacotherapy in Parkinson’s Disease
Florian Brugger, Stefan Hägele-Link
Cambridge University Press eBooks (2025), pp. 290-305
Closed Access
Experimental Therapeutics in Parkinson’s Disease
Priti Gros, Luis Elías Galicia García, Susan H. Fox
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 399-426
Closed Access
Metallothionein II treatment mitigates rotenone-induced neurodegeneration in zebrafish models of Parkinson’s disease
Yong Hui Nies, Wei Ling Lim, Nurul Huda Abd Karim, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
How to advance the pharmacological management of cognitive impairment in Parkinson's disease
Carla Abdelnour, Lucy L. Gibson, Lucia Batzu, et al.
Journal of Parkinson s Disease (2025)
Open Access
Low doses of cannabis extract ameliorate non-motor symptoms of Parkinson’s disease patients: a case series
Ana Carolina Ruver-Martins, Ingrid Martínez, Vikram V. Holla, et al.
Frontiers in Human Neuroscience (2025) Vol. 18
Open Access
Approved cannabinoids for medical purposes – Comparative systematic review and meta-analysis for sleep and appetite
Rainer Spanagel, Ainhoa Bilbao
Neuropharmacology (2021) Vol. 196, pp. 108680-108680
Closed Access | Times Cited: 30
Cannabis and its derivatives for the use of motor symptoms in Parkinson’s disease: a systematic review and meta-analysis
Susan J. Thanabalasingam, Brandan Ranjith, Robyn Jackson, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top